EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

William G. Dixon; Loreto Carmona; Axel Finckh; Merete Lund Hetland; Tore K. Kvien; Robert Landewe; Joachim Listing; Paulo J. Nicola; Ulrik Tarp; Angela Zink; Johan Askling

doi:10.1136/ard.2009.125526

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

William G. Dixon^*, Loreto Carmona, Axel Finckh, Merete Lund Hetland, Tore K. Kvien, Robert Landewe, Joachim Listing, Paulo J. Nicola, Ulrik Tarp, Angela Zink, Johan Askling

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

66 Citations (Web of Science)

Original language	English
Pages (from-to)	1596-1602
Journal	Annals of the Rheumatic Diseases
Volume	69
Issue number	9
DOIs	https://doi.org/10.1136/ard.2009.125526
Publication status	Published - Sep 2010

Access to Document

10.1136/ard.2009.125526

Cite this

Dixon, William G. ; Carmona, Loreto ; Finckh, Axel ; Hetland, Merete Lund ; Kvien, Tore K. ; Landewe, Robert ; Listing, Joachim ; Nicola, Paulo J. ; Tarp, Ulrik ; Zink, Angela ; Askling, Johan. / EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. In: Annals of the Rheumatic Diseases. 2010 ; Vol. 69, No. 9. pp. 1596-1602.

@article{0c8bdb7713fd43e2ad34878c8c6837fa,

title = "EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology",

author = "Dixon, {William G.} and Loreto Carmona and Axel Finckh and Hetland, {Merete Lund} and Kvien, {Tore K.} and Robert Landewe and Joachim Listing and Nicola, {Paulo J.} and Ulrik Tarp and Angela Zink and Johan Askling",

year = "2010",

month = sep,

doi = "10.1136/ard.2009.125526",

language = "English",

volume = "69",

pages = "1596--1602",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "9",

}

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. / Dixon, William G.; Carmona, Loreto; Finckh, Axel; Hetland, Merete Lund; Kvien, Tore K.; Landewe, Robert; Listing, Joachim; Nicola, Paulo J.; Tarp, Ulrik; Zink, Angela; Askling, Johan.

In: Annals of the Rheumatic Diseases, Vol. 69, No. 9, 09.2010, p. 1596-1602.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

AU - Dixon, William G.

AU - Carmona, Loreto

AU - Finckh, Axel

AU - Hetland, Merete Lund

AU - Kvien, Tore K.

AU - Landewe, Robert

AU - Listing, Joachim

AU - Nicola, Paulo J.

AU - Tarp, Ulrik

AU - Zink, Angela

AU - Askling, Johan

PY - 2010/9

Y1 - 2010/9

U2 - 10.1136/ard.2009.125526

DO - 10.1136/ard.2009.125526

M3 - Article

C2 - 20525843

VL - 69

SP - 1596

EP - 1602

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 9

ER -